Dominique Arpin, Julien Gautier, Audrey Mansuet-Lupo, Romain Corre, Aymeric De Monfort, Sylvie Chabaud, Chantal Decroisette Phan Van Ho, Sébastien Couraud, Marie Wislez, Simonneau Yannick, Solene Chaleat, Charles Ricordel, Anne Claire Toffart, Didier Debieuvre, Ivana Sondarjee, Jean-Bernard Auliac, Diane Damotte, Laurent Greillier, David Pérol, Luc Odier. "FIRST-NEC (GFPC 01-2022): A multicenter phase II study evaluating the efficacy and safety of the combination of durvalumab with etoposide and platinum as first line treatment in patients with advanced large-cell neuroendocrine lung carcinomas (LCNECs).." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.tps8657